{"id":"https://openalex.org/W1978462890","doi":"https://doi.org/10.7164/antibiotics.43.1590","title":"Deoxyspergualin therapy in autoimmune MRL/1pr mice suffering advanced lupus-like disease.","display_name":"Deoxyspergualin therapy in autoimmune MRL/1pr mice suffering advanced lupus-like disease.","publication_year":1990,"publication_date":"1990-01-01","ids":{"openalex":"https://openalex.org/W1978462890","doi":"https://doi.org/10.7164/antibiotics.43.1590","mag":"1978462890","pmid":"https://pubmed.ncbi.nlm.nih.gov/2276976"},"language":"en","primary_location":{"id":"doi:10.7164/antibiotics.43.1590","doi":"https://doi.org/10.7164/antibiotics.43.1590","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.43.1590","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/43/12/43_12_1590/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/43/12/43_12_1590/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110135434","display_name":"Kyuichi Nemoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"KYUICHI NEMOTO","raw_affiliation_strings":["Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd., Tokyo, Japan","Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd., Tokyo, Japan","institution_ids":["https://openalex.org/I4210150228"]},{"raw_affiliation_string":"Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072435963","display_name":"TAKAKO MAE","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"TAKAKO MAE","raw_affiliation_strings":["Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075251788","display_name":"Yumi Sugawara","orcid":"https://orcid.org/0000-0002-0197-6772","observed_orcids":["https://orcid.org/0000-0002-0197-6772"]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"YUMI SUGAWARA","raw_affiliation_strings":["Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026457367","display_name":"Michiko Hayashi","orcid":"https://orcid.org/0000-0002-3666-7814","observed_orcids":["https://orcid.org/0000-0002-3666-7814"]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"MICHIKO HAYASHI","raw_affiliation_strings":["Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108196353","display_name":"Fuminori Abe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"FUMINORI ABE","raw_affiliation_strings":["Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103855412","display_name":"TOMIO TAKEUCHI","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"TOMIO TAKEUCHI","raw_affiliation_strings":["Institute of Microbial Chemistry"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Microbial Chemistry","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":null,"fwci":1.2307,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.78017163,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"43","issue":"12","first_page":"1590","last_page":"1596"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/deoxyspergualin","display_name":"deoxyspergualin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":0.8999999761581421},{"id":"https://openalex.org/keywords/mrl-lpr-mice","display_name":"MRL/lpr mice","score":0.949999988079071},{"id":"https://openalex.org/keywords/autoimmune-disease-treatment","display_name":"autoimmune disease therapy","score":0.6800000071525574},{"id":"https://openalex.org/keywords/immunosuppressive-drugs","display_name":"immunosuppressants","score":0.9679999947547913},{"id":"https://openalex.org/keywords/hyperuremia","display_name":"hyperuremia","score":0.8450000286102295},{"id":"https://openalex.org/keywords/disease-stage","display_name":"disease stage","score":0.3070000112056732},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.3580000102519989}],"concepts":[{"id":"https://openalex.org/C2776912625","wikidata":"https://www.wikidata.org/wiki/Q1485","display_name":"Systemic lupus erythematosus","level":3,"score":0.6596285104751587},{"id":"https://openalex.org/C2779075594","wikidata":"https://www.wikidata.org/wiki/Q8084905","display_name":"Autoimmune disease","level":3,"score":0.6253905296325684},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.603223979473114},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4872237741947174},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.45473983883857727},{"id":"https://openalex.org/C2778617581","wikidata":"https://www.wikidata.org/wiki/Q41873","display_name":"Beta-lactam","level":3,"score":0.4300508201122284},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3399617671966553},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24803778529167175},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18958348035812378},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.18209972977638245},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.13447225093841553}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001806","descriptor_name":"Blood Urea Nitrogen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005921","descriptor_name":"Glomerulonephritis","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D005921","descriptor_name":"Glomerulonephritis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D006146","descriptor_name":"Guanidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014511","descriptor_name":"Uremia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.7164/antibiotics.43.1590","doi":"https://doi.org/10.7164/antibiotics.43.1590","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.43.1590","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/43/12/43_12_1590/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},{"id":"pmid:2276976","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2276976","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antibiotics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.7164/antibiotics.43.1590","doi":"https://doi.org/10.7164/antibiotics.43.1590","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.43.1590","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/43/12/43_12_1590/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1978462890.pdf","grobid_xml":"https://content.openalex.org/works/W1978462890.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1566543630","https://openalex.org/W1999247918","https://openalex.org/W1999931966","https://openalex.org/W2000466028","https://openalex.org/W2020823003","https://openalex.org/W2022054126","https://openalex.org/W2030410237","https://openalex.org/W2052793895","https://openalex.org/W2060614195","https://openalex.org/W2071069690","https://openalex.org/W2072145209","https://openalex.org/W2087145799","https://openalex.org/W2093660893","https://openalex.org/W2094633801","https://openalex.org/W2124895467","https://openalex.org/W2130068789","https://openalex.org/W2137844313","https://openalex.org/W2314738454"],"related_works":["https://openalex.org/W2071069690","https://openalex.org/W2047866050","https://openalex.org/W2081505033","https://openalex.org/W2060614195","https://openalex.org/W2062376927","https://openalex.org/W2038476414","https://openalex.org/W2020823003","https://openalex.org/W2640331333","https://openalex.org/W2112278760","https://openalex.org/W2032753988"],"abstract_inverted_index":{"The":[0],"present":[1],"study":[2],"was":[3,56,127],"designed":[4],"to":[5,63,129],"evaluate":[6],"the":[7,34,38,49,70,83,103,106,119],"therapeutic":[8],"activity":[9],"of":[10,37,42,51,69,76,88,99,118],"a":[11,72,86,97,131],"novel":[12],"immunosuppressive":[13],"agent,":[14],"deoxyspergualin":[15],"(DSG,":[16],"NKT-01)":[17],"in":[18,33,66],"male":[19],"MRL/MpJ-lpr/lpr":[20],"(MRL/lpr)":[21],"mice":[22,65],"suffering":[23],"advanced":[24,67],"systemic":[25],"lupus":[26],"erythematosus":[27],"(SLE)-like":[28],"lesions.":[29,53],"Treatment":[30],"with":[31],"DSG":[32,55,94,126],"early":[35],"phase":[36],"disease":[39],"at":[40,96,102],"doses":[41],"1.5":[43,89],"and":[44],"3":[45,77],"mg/kg":[46,78,90],"strongly":[47],"suppressed":[48],"development":[50],"SLE-like":[52],"When":[54],"administered":[57],"from":[58],"week":[59],"21":[60],"through":[61],"29":[62],"MRL/lpr":[64],"phases":[68],"disease,":[71],"daily":[73],"iv":[74],"dose":[75,87,98],"(5":[79],"days/week)":[80],"markedly":[81],"reduced":[82],"symptoms,":[84],"whereas":[85],"did":[91],"not.":[92],"Moreover,":[93],"treatment":[95],"3mg/kg,":[100],"started":[101],"time":[104],"when":[105],"blood":[107],"urea":[108],"nitrogen":[109],"levels":[110],"were":[111],"over":[112],"50":[113],"mg/deciliter,":[114],"significantly":[115],"prevented":[116],"deterioration":[117],"hyperuremia.":[120],"Taking":[121],"these":[122],"findings":[123],"into":[124],"consideration,":[125],"found":[128],"be":[130],"promising":[132],"agent":[133],"for":[134],"curing":[135],"such":[136],"established":[137],"autoimmune":[138],"disease.":[139]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}